Kissei Pharmaceutical Co., Ltd. (4547.T) Financials
4547.T Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
Sept. 30, 2024 | 260.3 billion | 39.6 billion |
June 30, 2024 | 257.9 billion | 16.0 billion |
March 31, 2024 | 260.9 billion | 39.8 billion |
Dec. 31, 2023 | 228.5 billion | 30.9 billion |
4547.T Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
Sept. 30, 2024 | ? | ? |
June 30, 2024 | ? | ? |
March 31, 2024 | ? | ? |
Dec. 31, 2023 | 2.1 billion | ? |
4547.T Net Income
Date | Net Income |
---|---|
Sept. 30, 2024 | ? |
June 30, 2024 | 4.1 billion |
March 31, 2024 | 2.8 billion |
Dec. 31, 2023 | 2.7 billion |
4547.T Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
Sept. 30, 2024 | 50.0 billion | - | - |
June 30, 2024 | 45.9 billion | - | - |
March 31, 2024 | 45.9 billion | - | 236.0 million |
Dec. 31, 2023 | 43.2 billion | - | 624.0 million |
4547.T Shares Outstanding
4547.T Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
Sept. 30, 2024 | - | - | 10.9 billion | - |
June 30, 2024 | - | 2.6 billion | 8.7 billion | - |
March 31, 2024 | - | 2.7 billion | 6.2 billion | - |
Dec. 31, 2023 | - | 2.3 billion | 5.9 billion | - |
4547.T Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
Sept. 30, 2024 | 21.3 billion | 10.8 billion |
June 30, 2024 | 21.2 billion | 10.3 billion |
March 31, 2024 | 17.7 billion | 8.9 billion |
Dec. 31, 2023 | 20.9 billion | 10.6 billion |
4547.T
Price: ¥4,180
Forward Dividend Yield: 2.15%
Payout Ratio: 33.50%
Dividend Per Share: 90.00 JPY
Earnings Per Share: 274.20 JPY
P/E Ratio: 15.43
Exchange: JPX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 181.1 billion
Average Dividend Frequency: 2
Years Paying Dividends: 25
DGR3: 16.35%
DGR5: 11.38%
DGR10: 7.97%
DGR20: 30.00%